Michael Sela
Michael Sela (Hebrew: מיכאל סלע ; Mieczysław Salomonowicz; 2 March 1924 – 27 May 2022) was a Polish-born Israeli immunologist. He was the W. Garfield Weston Professor of Immunology at the Weizmann Institute of Science in Rehovot.[1] He was the president of the Weizmann Institute of Science from 1975 until 1985.[2] He was probably best known as the co-developer (with Ruth Arnon and Dvora Teitelbaum) of the multiple sclerosis drug copaxone.
Michael Sela | |
---|---|
מיכאל סלע | |
Born | Mieczysław Salomonowicz 2 March 1924 Tomaszów Mazowiecki, Poland |
Died | 27 May 2022 (aged 98) |
Nationality | Israeli |
Occupation | immunologist |
Known for |
|
Title | W. Garfield Weston Professor of Immunology at the Weizmann Institute of Science |
Awards |
|
Sela died on 27 May 2022 at the age of 98.[3]
References
- ↑ Michael Sela at the Weizmann Institute of Science
- ↑ "Prof. Michael Sela | Still hard at work, pursuing the understanding of immunology | WeizmannCompass". Weizmann.ac.il. 2017-06-04. Retrieved 2020-02-10.
- ↑ "מסע הקסם המדעי - חדשות מדע, תגליות ומידע לציבור מבית מכון ויצמן למדע". מסע הקסם המדעי - חדשות מדע, תגליות ומידע לציבור מבית מכון ויצמן למדע (in עברית). Retrieved 2022-05-28.